Allen Kaplan to Humans
This is a "connection" page, showing publications Allen Kaplan has written about Humans.
Connection Strength
1.774
-
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances. Allergy. 2023 02; 78(2):389-401.
Score: 0.032
-
Bradykinin formation by mutant plasminogen. Blood. 2022 05 05; 139(18):2732-2733.
Score: 0.031
-
Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. J Allergy Clin Immunol Pract. 2022 03; 10(3):716-722.
Score: 0.030
-
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema. Clin Rev Allergy Immunol. 2021 Jun; 60(3):348-356.
Score: 0.029
-
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells. J Allergy Clin Immunol Pract. 2021 06; 9(6):2195-2208.
Score: 0.029
-
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which. J Allergy Clin Immunol Pract. 2021 03; 9(3):1067-1078.
Score: 0.028
-
Hereditary angioedema: Investigational therapies and future research. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S51-S54.
Score: 0.028
-
Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients. J Allergy Clin Immunol. 2021 Feb; 147(2):507-509.
Score: 0.028
-
Diagnosis and treatment of chronic spontaneous urticaria. Allergy. 2020 07; 75(7):1830-1832.
Score: 0.026
-
Preventing anaphylaxis fatalities: Should we target bradykinin? J Allergy Clin Immunol. 2020 05; 145(5):1365-1366.
Score: 0.026
-
C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema. J Allergy Clin Immunol Pract. 2020 03; 8(3):892-900.
Score: 0.026
-
Treatment of urticaria: a clinical and mechanistic approach. Curr Opin Allergy Clin Immunol. 2019 08; 19(4):387-392.
Score: 0.025
-
Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 08; 144(2):622-623.
Score: 0.025
-
Chronic Spontaneous Urticaria: The Devil's Itch. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1097-1106.
Score: 0.024
-
Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy Asthma Proc. 2018 May 01; 39(3):184-190.
Score: 0.023
-
Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study. J Am Acad Dermatol. 2018 04; 78(4):793-795.
Score: 0.022
-
Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade. Immunol Allergy Clin North Am. 2017 08; 37(3):513-525.
Score: 0.022
-
Reply. J Allergy Clin Immunol. 2017 05; 139(5):1720-1721.
Score: 0.022
-
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533.
Score: 0.021
-
Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. J Allergy Clin Immunol. 2017 Jul; 140(1):170-176.
Score: 0.021
-
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Clin Rev Allergy Immunol. 2016 Oct; 51(2):207-15.
Score: 0.021
-
Fibrinolysis and bradykinin formation: From in?vitro observations to human disease in "just" 45?years. J Allergy Clin Immunol. 2016 11; 138(5):1424-1425.
Score: 0.021
-
Vibratory Urticaria and ADGRE2. N Engl J Med. 2016 07 07; 375(1):94-5.
Score: 0.021
-
Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol. 2016 Feb; 137(2):474-81.
Score: 0.020
-
Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy Clin Immunol. 2016 06; 137(6):1822-1829.e1.
Score: 0.019
-
How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria. J Allergy Clin Immunol Pract. 2015 Jul-Aug; 3(4):648.
Score: 0.019
-
The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. Allergy Asthma Proc. 2014 Nov-Dec; 35(6):444-53.
Score: 0.018
-
A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes. Allergy. 2015 Jan; 70(1):115-9.
Score: 0.018
-
Biologic agents and the therapy of chronic spontaneous urticaria. Curr Opin Allergy Clin Immunol. 2014 Aug; 14(4):347-53.
Score: 0.018
-
Bradykinin-mediated diseases. Chem Immunol Allergy. 2014; 100:140-7.
Score: 0.018
-
The bradykinin-forming cascade: a historical perspective. Chem Immunol Allergy. 2014; 100:205-13.
Score: 0.018
-
Therapy of chronic urticaria: a simple, modern approach. Ann Allergy Asthma Immunol. 2014 May; 112(5):419-25.
Score: 0.018
-
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol. 2014; 121:41-89.
Score: 0.017
-
The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014; 24(1):1-5.
Score: 0.017
-
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
Score: 0.017
-
In vitro comparison of bradykinin degradation by aliskiren, a renin inhibitor, and an inhibitor of angiotensin-converting enzyme. J Renin Angiotensin Aldosterone Syst. 2015 Jun; 16(2):321-7.
Score: 0.017
-
Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol. 2013 Aug; 132(2):470-5.
Score: 0.017
-
Biologic agents in the treatment of urticaria. Curr Allergy Asthma Rep. 2012 Aug; 12(4):288-91.
Score: 0.016
-
What to do with refractory urticaria patients. Curr Allergy Asthma Rep. 2011 Jun; 11(3):189-91.
Score: 0.014
-
Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011 May; 127(5):1300-2.
Score: 0.014
-
Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010 Nov; 126(5):918-25.
Score: 0.014
-
The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010 Aug; 47(13):2161-9.
Score: 0.014
-
Kinins, airway obstruction, and anaphylaxis. Chem Immunol Allergy. 2010; 95:67-84.
Score: 0.013
-
Kinin formation in C1 inhibitor deficiency. J Allergy Clin Immunol. 2010 Jun; 125(6):1411-2; author reply 1412.
Score: 0.013
-
The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010 Mar; 104(3):193-204.
Score: 0.013
-
Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Ann Allergy Asthma Immunol. 2010 Jan; 104(1):50-4.
Score: 0.013
-
Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009 Jul; 124(1):143-9.
Score: 0.012
-
What the first 10,000 patients with chronic urticaria have taught me: a personal journey. J Allergy Clin Immunol. 2009 Mar; 123(3):713-7.
Score: 0.012
-
Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
Score: 0.012
-
Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):279-86.
Score: 0.012
-
Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr). 2007 Mar-Apr; 35(2):57-61.
Score: 0.011
-
Angioedema. J Am Acad Dermatol. 2005 Sep; 53(3):373-88; quiz 389-92.
Score: 0.010
-
Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2005 Jul; 289(1):H251-7.
Score: 0.010
-
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2005 Jun; 94(6):662-9.
Score: 0.010
-
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005 May; 35(5):554-9.
Score: 0.009
-
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005 Apr; 115(4):815-21.
Score: 0.009
-
A new mechanism for immunologic initiation of asthma. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1267-8.
Score: 0.009
-
Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol. 2005; 86:159-208.
Score: 0.009
-
Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. A.P. Kaplan. Clin Exp Allergy. 2004 Nov; 34(11):1803; author reply 1804-5.
Score: 0.009
-
Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004 Sep; 114(3):465-74; quiz 475.
Score: 0.009
-
Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb Haemost. 2004 Jan; 91(1):61-70.
Score: 0.009
-
High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes. Thromb Haemost. 2003 Nov; 90(5):787-95.
Score: 0.009
-
Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells. J Thromb Haemost. 2003 Nov; 1(11):2444-9.
Score: 0.009
-
IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7.
Score: 0.008
-
Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol. 2003 Jul; 112(1):218.
Score: 0.008
-
Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90. Int Immunopharmacol. 2002 Dec; 2(13-14):1851-9.
Score: 0.008
-
Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Int Immunopharmacol. 2002 Dec; 2(13-14):1875-85.
Score: 0.008
-
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700.
Score: 0.008
-
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022 07; 77(7):1961-1990.
Score: 0.008
-
Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002 Jan 17; 346(3):175-9.
Score: 0.008
-
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2):896-900.
Score: 0.008
-
A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002 Jan; 109(1):114-8.
Score: 0.008
-
Immediate pressure urticaria. Allergy. 2002 Jan; 57(1):56-7.
Score: 0.008
-
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems. Front Immunol. 2021; 12:767347.
Score: 0.007
-
The international EAACI/GA?LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 03; 77(3):734-766.
Score: 0.007
-
gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema. Inflammation. 2022 Feb; 45(1):116-128.
Score: 0.007
-
Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor. Mol Immunol. 2021 08; 136:150-160.
Score: 0.007
-
A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema. J Allergy Clin Immunol Pract. 2021 06; 9(6):2284-2292.
Score: 0.007
-
Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol. 2001 Apr; 124(4):423-31.
Score: 0.007
-
Activation of the kinin-forming cascade on the surface of endothelial cells. Biol Chem. 2001 Jan; 382(1):71-5.
Score: 0.007
-
Activation of the plasma kinin forming cascade along cell surfaces. Int Arch Allergy Immunol. 2001 Jan-Mar; 124(1-3):339-42.
Score: 0.007
-
C1 inhibitor deficiency: hereditary and acquired forms. J Investig Allergol Clin Immunol. 2001; 11(4):211-9.
Score: 0.007
-
Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence. Allergy. 2020 08; 75(8):2115-2123.
Score: 0.007
-
Protease activity in single-chain prekallikrein. Blood. 2020 02 20; 135(8):558-567.
Score: 0.007
-
sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. Mol Immunol. 2020 03; 119:27-34.
Score: 0.007
-
Diagnostic tests for urticaria and angioedema. Clin Allergy Immunol. 2000; 15:111-26.
Score: 0.007
-
Pathogenesis and treatment of chronic urticaria. Postgrad Med. 1999 Dec; 106(7 Suppl):12-7.
Score: 0.007
-
Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol. 1999 Sep; 92(3):246-55.
Score: 0.006
-
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology. 1999 Sep; 43(2-3):203-10.
Score: 0.006
-
Nomenclature of factor XI and the contact system. J Thromb Haemost. 2019 12; 17(12):2216-2219.
Score: 0.006
-
Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med. 1999 Aug; 5(8):555-63.
Score: 0.006
-
Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol. 1999 Jul; 104(1):169-72.
Score: 0.006
-
Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein. Clin Immunol. 1999 Jan; 90(1):89-99.
Score: 0.006
-
An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23) Allergy. 1998 Jul; 53(7):631-2.
Score: 0.006
-
Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998 May; 101(5):672-6.
Score: 0.006
-
Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor. Biochem Pharmacol. 1998 Apr 15; 55(8):1175-80.
Score: 0.006
-
Chemokines and the late-phase reaction. Allergy. 1998; 53(45 Suppl):27-32.
Score: 0.006
-
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria. J Allergy Clin Immunol. 2018 03; 141(3):1138-1139.e7.
Score: 0.006
-
Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1715-1721.
Score: 0.006
-
Binding of activation of kinin-forming proteins on vascular endothelial cells. Immunopharmacology. 1997 Jun; 36(2-3):201-7.
Score: 0.005
-
Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5.
Score: 0.005
-
Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria. Ann Allergy Asthma Immunol. 2017 04; 118(4):524.
Score: 0.005
-
The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv Immunol. 1997; 66:225-72.
Score: 0.005
-
The complement and contact activation systems: partnership in pathogenesis beyond angioedema. Immunol Rev. 2016 11; 274(1):281-289.
Score: 0.005
-
Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A. 1996 Aug 06; 93(16):8552-7.
Score: 0.005
-
Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells. Clin Exp Allergy. 1996 Aug; 26(8):926-33.
Score: 0.005
-
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Ann Allergy Asthma Immunol. 2016 10; 117(4):370-377.e1.
Score: 0.005
-
Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology. 1996 Jun; 33(1-3):311-3.
Score: 0.005
-
Interactions of factor XII with platelets and endothelial cells. Immunopharmacology. 1996 May; 32(1-3):24-7.
Score: 0.005
-
Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996 Jan; 97(1 Pt 1):104-12.
Score: 0.005
-
Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine. Allergy Asthma Proc. 1996 Jan-Feb; 17(1):5-11.
Score: 0.005
-
Rapid oral desensitization to sirolimus in a patient with lymphangioleiomyomatosis. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):352-3.
Score: 0.005
-
Chemokines and the allergic response. Exp Dermatol. 1995 Aug; 4(4 Pt 2):260-5.
Score: 0.005
-
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. J Allergy Clin Immunol Pract. 2015 Sep-Oct; 3(5):743-50.e1.
Score: 0.005
-
Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells. Int Arch Allergy Immunol. 1995 May-Jun; 107(1-3):93-4.
Score: 0.005
-
Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J Allergy Clin Immunol. 1995 Feb; 95(2):574-86.
Score: 0.005
-
Chemokines as allergic mediators--relationship to histamine-releasing factors. Allergy. 1994 Aug; 49(7):495-501.
Score: 0.004
-
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014 May; 69(5):602-16.
Score: 0.004
-
Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012. Inflamm Res. 2014 Mar; 63(3):173-8.
Score: 0.004
-
Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem. 1993 Jun 05; 268(16):11982-7.
Score: 0.004
-
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993 Mar 01; 150(5):1932-43.
Score: 0.004
-
Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood. 1993 Mar 01; 81(5):1306-11.
Score: 0.004
-
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35.
Score: 0.004
-
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One. 2013; 8(2):e53773.
Score: 0.004
-
Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012 Nov-Dec; 33 Suppl 1:S145-56.
Score: 0.004
-
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15; 149(2):636-42.
Score: 0.004
-
Effect of Neurotropin on the activation of the plasma kallikrein-kinin system. Biochem Pharmacol. 1992 Mar 17; 43(6):1361-9.
Score: 0.004
-
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol. 1992 Mar; 89(3):666-72.
Score: 0.004
-
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93.
Score: 0.004
-
Cytokine stimulation of human basophil histamine release. Immunol Ser. 1992; 57:573-86.
Score: 0.004
-
Studies of the activation and inhibition of the plasma kallikrein-kinin system. Agents Actions Suppl. 1992; 38 ( Pt 3):317-28.
Score: 0.004
-
IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol. 1991 Sep 15; 147(6):1920-4.
Score: 0.004
-
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011 Sep; 128(3):567-73.e1.
Score: 0.004
-
Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):506-16.
Score: 0.004
-
Histamine releasing factors. Clin Exp Allergy. 1991 Jan; 21 Suppl 1:8-16.
Score: 0.004
-
Histamine-releasing factors. Int Arch Allergy Appl Immunol. 1991; 94(1-4):148-53.
Score: 0.004
-
Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol. 1991; 50:237-60.
Score: 0.004
-
Unmet clinical needs in chronic spontaneous urticaria. A GA?LEN task force report. Allergy. 2011 Mar; 66(3):317-30.
Score: 0.003
-
Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):765-75.
Score: 0.003
-
Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):142-8.
Score: 0.003
-
Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin. Mol Cell Neurosci. 2010 Nov; 45(3):226-33.
Score: 0.003
-
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest. 1990 May; 85(5):1516-21.
Score: 0.003
-
Urticaria: the relationship of duration of lesion to pathogenesis. Allergy Proc. 1990 Jan-Feb; 11(1):15-8.
Score: 0.003
-
Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. 1989 Aug 01; 74(2):695-702.
Score: 0.003
-
Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation. 1989 Jun; 13(3):295-308.
Score: 0.003
-
Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009 Jun; 39(6):777-87.
Score: 0.003
-
Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. 1989 Apr 21; 119(1):19-25.
Score: 0.003
-
Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest. 1989 Apr; 83(4):1204-10.
Score: 0.003
-
Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products. Biochem Pharmacol. 1989 Mar 15; 38(6):993-1000.
Score: 0.003
-
Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma. Adv Exp Med Biol. 1989; 247B:317-24.
Score: 0.003
-
Relationship of Hageman factor activation to the formation of bradykinin in humans: a historical perspective. Prog Clin Biol Res. 1989; 297:311-23.
Score: 0.003
-
Pathways of kinin formation and role in allergic diseases. Clin Immunol Immunopathol. 1989 Jan; 50(1 Pt 2):S41-51.
Score: 0.003
-
Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol. 1988 Oct 15; 141(8):2688-92.
Score: 0.003
-
Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol. 1988 Aug; 82(2):218-23.
Score: 0.003
-
Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum. 1988 Aug; 31(8):1000-6.
Score: 0.003
-
Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest. 1988 Jul; 82(1):17-20.
Score: 0.003
-
Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. 1988 May; 71(5):1334-40.
Score: 0.003
-
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7.
Score: 0.003
-
Mediators of inflammation: an overview. Methods Enzymol. 1988; 163:3-23.
Score: 0.003
-
Human Hageman factor and its fragments. Methods Enzymol. 1988; 163:68-80.
Score: 0.003
-
Prekallikrein. Methods Enzymol. 1988; 163:85-95.
Score: 0.003
-
Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988; 6:49-83.
Score: 0.003
-
Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin. J Immunol. 1987 Oct 15; 139(8):2744-8.
Score: 0.003
-
The coagulation-kinin pathway of human plasma. Blood. 1987 Jul; 70(1):1-15.
Score: 0.003
-
Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol. 2007 Sep; 120(3):729-30.
Score: 0.003
-
Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor. J Biol Chem. 1986 Nov 15; 261(32):14965-8.
Score: 0.003
-
Surfactant protein A and D in human sinus mucosa: a preliminary report. ORL J Otorhinolaryngol Relat Spec. 2007; 69(1):57-60.
Score: 0.003
-
Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):914-8.
Score: 0.003
-
Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci. 2006 Sep; 332(3):148-52.
Score: 0.003
-
Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum. 1986 Aug; 29(8):944-55.
Score: 0.003
-
The effect of C1 inhibitor upon Hageman factor autoactivation. Blood. 1986 Jul; 68(1):239-43.
Score: 0.003
-
The intrinsic coagulation/kinin pathway--the classical complement pathway and their interactions. Adv Exp Med Biol. 1986; 198 Pt B:11-25.
Score: 0.002
-
Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay. Blood. 1985 Sep; 66(3):636-41.
Score: 0.002
-
Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes. J Biol Chem. 1985 Apr 10; 260(7):4257-63.
Score: 0.002
-
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
Score: 0.002
-
Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2005 Mar; 115(3):584-91.
Score: 0.002
-
Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8.
Score: 0.002
-
Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004 Nov; 131(5):585-9.
Score: 0.002
-
Drug-induced skin disease. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 2):573-9.
Score: 0.002
-
World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Immunol. 2004 Sep; 135(1):83-92.
Score: 0.002
-
Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol. 2004 Sep; 93(3):299-303.
Score: 0.002
-
Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators. Clin Immunol Immunopathol. 1984 Jul; 32(1):101-10.
Score: 0.002
-
Exercise-induced hives. J Allergy Clin Immunol. 1984 May; 73(5 Pt 2):704-7.
Score: 0.002
-
Immunoreactive tissue kallikrein in human serum. J Lab Clin Med. 1984 May; 103(5):731-8.
Score: 0.002
-
Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984 Apr; 73(4):453-6.
Score: 0.002
-
Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Fed Proc. 1983 Nov; 42(14):3123-7.
Score: 0.002
-
Chronic urticaria. Possible causes, suggested treatment alternatives. Postgrad Med. 1983 Sep; 74(3):209-15, 218-22.
Score: 0.002
-
Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol. 1983 Jul; 72(1):54-60.
Score: 0.002
-
Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 1983 May; 71(5):1450-6.
Score: 0.002
-
Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83.
Score: 0.002
-
Mechanisms of bradykinin generation in human plasma. Monogr Allergy. 1983; 18:272-6.
Score: 0.002
-
Initiation of contact activation of human plasma. Adv Exp Med Biol. 1983; 156:45-61.
Score: 0.002
-
Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood. 1982 Jul; 60(1):64-70.
Score: 0.002
-
The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. J Biol Chem. 1982 Feb 25; 257(4):1779-84.
Score: 0.002
-
Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Ann N Y Acad Sci. 1982; 389:25-38.
Score: 0.002
-
Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol. 1981 Dec; 68(6):438-41.
Score: 0.002
-
Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7.
Score: 0.002
-
Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol. 1981 Oct; 68(4):319-24.
Score: 0.002
-
The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol. 1981 Sep; 3(1):75-93.
Score: 0.002
-
Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 2001 Sep; 108(3):394-401.
Score: 0.002
-
Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 1981 Aug; 68(2):103-5.
Score: 0.002
-
The pathogenic basis of urticaria and angioedema: recent advances. Am J Med. 1981 Apr; 70(4):755-8.
Score: 0.002
-
Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med. 1981 Mar 01; 153(3):665-76.
Score: 0.002
-
The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb Res. 1980 Oct 15; 20(2):173-89.
Score: 0.002
-
The physical urticarias. Int J Dermatol. 1980 Oct; 19(8):417-35.
Score: 0.002
-
Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem. 1980 Aug 10; 255(15):7281-6.
Score: 0.002
-
The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol. 1980 Apr; 65(4):309-12.
Score: 0.002
-
Autoactivatability of human Hageman factor (factor XII). Biochem Biophys Res Commun. 1980 Feb 12; 92(3):803-10.
Score: 0.002
-
Plasmin can activate plasma prorenin but is not required for the alkaline phase of acid activation. Clin Sci (Lond). 1979 Dec; 57 Suppl 5:97s-99s.
Score: 0.002
-
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8.
Score: 0.002
-
Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Proc Natl Acad Sci U S A. 1979 Nov; 76(11):5914-8.
Score: 0.002
-
Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Blood. 1979 Oct; 54(4):850-62.
Score: 0.002
-
Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci U S A. 1979 Oct; 76(10):4862-6.
Score: 0.002
-
Contrast agents and anaphylactic-like reactions. J Allergy Clin Immunol. 1979 Apr; 63(4):225-7.
Score: 0.002
-
Evaluation of a patient with cold and cholinergic urticaria. J Allergy Clin Immunol. 1979 Jan; 63(1):35-8.
Score: 0.002
-
The role of high molecular weight kininogen in contact activation of coagulation, fibrinolysis and kinin generation. Adv Exp Med Biol. 1979; 120B:71-91.
Score: 0.002
-
Structure-function correlation of human kininogen. Monogr Allergy. 1979; 14:212-7.
Score: 0.002
-
Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol. 1978 Jun; 61(6):350-4.
Score: 0.001
-
Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J Exp Med. 1978 Feb 01; 147(2):488-99.
Score: 0.001
-
Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998; 16(4):403-29.
Score: 0.001
-
Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest. 1977 Dec; 60(6):1376-80.
Score: 0.001
-
Mediators of urticaria and angioedema. J Allergy Clin Immunol. 1977 Nov; 60(5):324-32.
Score: 0.001
-
Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10; 252(17):6097-104.
Score: 0.001
-
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest. 1977 Jul; 60(1):18-31.
Score: 0.001
-
Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clin Exp Allergy. 1997 Jun; 27(6):653-63.
Score: 0.001
-
The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis. Monogr Allergy. 1977; 12:120-30.
Score: 0.001
-
Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34.
Score: 0.001
-
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov; 73(11):4179-83.
Score: 0.001
-
Human C1q induces eosinophil migration. Clin Immunol Immunopathol. 1996 Oct; 81(1):48-54.
Score: 0.001
-
The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation. Semin Thromb Hemost. 1976 Jul; 3(1):1-26.
Score: 0.001
-
Pattern of nasal secretions during experimental influenza virus infection. Rhinology. 1996 Mar; 34(1):2-8.
Score: 0.001
-
Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response. J Allergy Clin Immunol. 1975 Dec; 56(6):491-506.
Score: 0.001
-
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975 Dec; 56(6):1650-62.
Score: 0.001
-
Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells. Clin Exp Allergy. 1995 Sep; 25(9):890-5.
Score: 0.001
-
In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975 Jun; 55(6):394-402.
Score: 0.001
-
Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin. J Immunol. 1974 Dec; 113(6):1928-34.
Score: 0.001
-
Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin. J Exp Med. 1974 Dec 01; 140(6):1615-30.
Score: 0.001
-
Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions. Braz J Med Biol Res. 1994 Aug; 27(8):1817-28.
Score: 0.001
-
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest. 1974 Feb; 53(2):622-33.
Score: 0.001
-
The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest. 1973 Oct; 52(10):2591-5.
Score: 0.001
-
Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol. 1993 Mar; 3(9):1563-9.
Score: 0.001
-
Activation of factor XI in plasma is dependent on factor XII. Blood. 1993 Feb 01; 81(3):580-6.
Score: 0.001
-
The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med. 1972 Dec 01; 136(6):1378-93.
Score: 0.001
-
Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. Blood. 1992 Oct 15; 80(8):1980-8.
Score: 0.001
-
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan; 135(1):81-97.
Score: 0.001
-
A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med. 1971 Apr 01; 133(4):696-712.
Score: 0.001
-
The kallikrein-kinin system in inflammation. Adv Exp Med Biol. 1989; 247A:125-36.
Score: 0.001
-
Expression of functional cell surface C1-inactivator by U937 cells. Clin Immunol Immunopathol. 1988 Dec; 49(3):463-77.
Score: 0.001
-
Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83.
Score: 0.001
-
The IgE-dependent release of a Hageman factor cleaving factor from human lung. Am J Pathol. 1986 Apr; 123(1):146-54.
Score: 0.001
-
Quantitative assays of pharmacologic aerosols used in studying asthma. J Allergy Clin Immunol. 1985 Oct; 76(4):605-9.
Score: 0.001
-
Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937. J Immunol. 1985 Aug; 135(2):1313-9.
Score: 0.001
-
Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin. J Clin Invest. 1985 Aug; 76(2):413-9.
Score: 0.001
-
Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. J Biol Chem. 1983 May 25; 258(10):6415-21.
Score: 0.001
-
Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol. 1983 Feb; 26(2):249-57.
Score: 0.001
-
Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor. Ann N Y Acad Sci. 1981; 370:253-60.
Score: 0.000
-
Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. J Clin Invest. 1977 Jul; 60(1):7-17.
Score: 0.000
-
Inhibition of activated factor XII by antithrombin-heparin cofactor. J Biol Chem. 1976 Nov 10; 251(21):6481-8.
Score: 0.000
-
Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity. J Allergy Clin Immunol. 1976 Jun; 57(6):605-8.
Score: 0.000
-
Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor. Adv Exp Med Biol. 1976; 70(00):285-99.
Score: 0.000
-
The use of isoelectric focusing to study components of the human plasma kinin-forming system. Ann N Y Acad Sci. 1973 Jun 15; 209:372-86.
Score: 0.000
-
Plasma inhibitors of the components of the fibrinolytic pathway in man. J Clin Invest. 1973 Jun; 52(6):1394-401.
Score: 0.000
-
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest. 1973 Jun; 52(6):1402-9.
Score: 0.000